Patents

US 10398721 B2: Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

Granted
2019-09-03
Filed
2017-10-06 application 15727483
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are methods of treatment in subjects having progeroid diseases and related conditions which rely upon LMNA-targeted antisense oligonucleotides for reducing expression of one or more aberrantly spliced LMNA mRNA isoforms that encode progerin.

Source: PVGPATDIS, file of 2026-04-10 (ipg190903.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
SAREPTA THERAPEUTICS, INC. 126 patentsUS company or organizationCambridge, MASarepta Therapeutics, Inc. Form D issuer EXACT high confidence: identical full name and state
SAREPTA THERAPEUTICS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10
The United States of America, as represented by the Secretary, Department of Health and Human Services 1,434 patentsUS federal governmentBethesda, MDPVGPATDIS, file of 2026-04-10
UNIVERSITY OF MARYLAND 180 patentsUS company or organizationCollege Park, MDUNIVERSITY OF MARYLAND Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10
The Progeria Research Foundation 10 patentsUS company or organizationPeabody, MAThe Progeria Research Foundation, Inc. State business registration FUZZY medium confidence: same name (legal endings aside) and state
THE PROGERIA RESEARCH FOUNDATION INC Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Ryszard KoleCorvallis, OR24PVGPATDIS, file of 2026-04-10
Francis S. CollinsBethesda, MD12PVGPATDIS, file of 2026-04-10
Michael R. ErdosSeverna Park, MD5PVGPATDIS, file of 2026-04-10
Kan CaoBowie, MD7PVGPATDIS, file of 2026-04-10
Leslie B. GordonFoxborough, MA13PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/713PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P9/00PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/111PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-08-02Assignment
Assignment of assignor's interest
COLLINS, FRANCIS S. signed 2013-07-30
ERDOS, MICHAEL R. signed 2013-07-30
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES BETHESDA, MD46544/153ECORSEXC, file of 2026-09-25
2018-08-02Assignment
Assignment of assignor's interest
CAO, KAN signed 2015-04-20UNIVERSITY OF MARYLAND COLLEGE PARK, MD46544/92ECORSEXC, file of 2026-09-25
2018-08-02Assignment
Assignment of assignor's interest
KOLE, RYSZARD signed 2013-09-09SAREPTA THERAPEUTICS, INC. CORVALLIS, OR46544/70ECORSEXC, file of 2026-09-25
2018-06-15Assignment
Assignment of assignor's interest
GORDON, LESLIE B. signed 2018-03-25PROGERIA RESEARCH FOUNDATION, INC. PEABODY, MA46098/326ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.